Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Oncoimmunology|July 4, 2012
A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigenBenyamin Rosental, Uzi Hadad, Michael Brusilovsky, et al.
Frontiers in Immunology|April 21, 2017
Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant ExpressionTatiana Pazina, Avishai Shemesh, Michael Brusilovsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma productionAkiko Kikuchi-Maki, Sei-ichi Yusa, Tracey L Catina, et al.
Cell Reports|May 1, 2025
Molecular basis of β2 integrin activation by talin unveils subunit-specific mechanisms of integrin signalingTong Gao, Nicholas A Maskalenko, Salvin Kabir, et al.
The Journal of Biological Chemistry|March 18, 2015
Integrins Influence the Size and Dynamics of Signaling Microclusters in a Pyk2-dependent MannerMaria Steblyanko, Nadia Anikeeva, Kerry S Campbell, et al.
Frontiers in Immunology|November 21, 2018
In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T CellsAmanda G Tomalka, Ivelisse Resto-Garay, Kerry S Campbell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequenceKerry S Campbell, Sei-ichi Yusa, Akiko Kikuchi-Maki, et al.
Cancer Immunology, Immunotherapy : CII|December 22, 2017
Splice variants of human natural cytotoxicity receptors: novel innate immune checkpointsAvishai Shemesh, Michael Brusilovsky, Kiran Kundu, et al.
Frontiers in Immunology|May 7, 2026
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategiesAnirudh Rao, Christina Darwish, Kerry S Campbell, et al.
Cancer Immunology Research|December 12, 2024
The FcγRIIIA (CD16) L48-H/R Polymorphism Enhances NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity by Promoting Serial KillingNicholas A Maskalenko, Sam Zahroun, Oxana Tsygankova, et al.
Pageof 9